ESP Equity Partners
ESP Equity Partners is a private equity firm based in Bedminster, New Jersey, established in 2000. The firm specializes in acquiring pharmaceutical and medical assets, focusing on targeted therapeutic areas. Through its buyout fund, ESP Equity Partners I, the firm aims to invest in sectors such as pharmaceuticals, biotechnology, and healthcare devices and supplies. This strategic focus allows ESP Equity Partners to identify and leverage opportunities within the healthcare industry, contributing to advancements in medical innovation.
Top Regions
Top Stages
Beijing Jiahui Center Tower B,1107 6 JiQingLi, Chaoyang District Beijing, 100020, China
3 past transactions
EKR Therapeutics
Series D in 2008
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.
EKR Therapeutics
Series C in 2007
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.
EKR Therapeutics
Series B in 2006
EKR Therapeutics, Inc. is a specialty pharmaceutical company based in Bedminster, New Jersey, established in 2005. The company is dedicated to acquiring, developing, and commercializing prescription products specifically tailored for oncology supportive care and various acute-care hospital needs. EKR Therapeutics focuses on addressing a range of medical issues, including oral mucositis, stomatitis, dry mouth, nutritional challenges, cachexia, skin reactions, bone marrow depression, bone complications, pain management, nausea, vomiting, and diarrhea. By providing effective treatment options, EKR Therapeutics aims to enhance the quality of life for cancer patients and those experiencing acute medical conditions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.